51 results
Page 2 of 3
DEFA14A
u4bsb72 l4bi
28 Apr 21
Additional proxy soliciting materials
4:04pm
8-K
EX-99.1
17byln mr32a
10 Aug 20
UroGen Pharma Reports Second Quarter 2020 Financial Results and Recent Corporate Developments
7:20am
DEFA14A
ght1tfs2 rb8w
29 Apr 20
Additional proxy soliciting materials
6:53am
S-3
EX-1.1
r003bu4 aj2ievq8bt
20 Dec 19
Shelf registration
4:17pm
8-K
EX-99.2
6cq 1l22c7
24 Sep 19
Durability of Response Determined to be 89 Percent at Six Months and 84 Percent at 12 Months
5:20pm
10-Q
4xq1l aelw2zy92b69
9 May 19
Quarterly report
7:13am